chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: arm was very swollen; red; itchy; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 24Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included salbutamol sulfate (PROAIR), ethinylestradiol, levonorgestrel (SRONYX) and ibuprofen (MOTRIN) all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 the patient experienced arm was very swollen and felt like there was a knot right under the injection site for a week and it was also red and itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events arm was very swollen, red and itchy was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Swelling
Clinical narrative: Swelling; Reddness darkened; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8455) via an unspecified route of administration in the arm left on 06Apr2021 at 16:45(at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ascorbic acid, boswellia serrata resin, chondroitin sulfate, collagen, glucosamine hydrochloride, hyaluronic acid, manganese sulfate, methylsulfonylmethane, sodium, sodium borate (OSTEO BI-FLEX), ascorbic acid, tocopheryl acetate, glutathione, riboflavin, acetylcysteine, betacarotene, copper, zinc, selenium, bioflavonoids nos (ACCUVIT)  and omeprazole (PRILOSEC); all from unknown date for unknown indication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6955) via an unspecified route of administration in the arm left on 16Mar2021 at 16:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 06:00 the patient experienced Swelling subsided somewhat after 12-18 hours. Redness darkened and still continues 36 hours later. The was reported that she experienced Similar reaction 35 years ago to an unknown, airborne chemical that circulated through the ventilation system in a building where she was working. Dermatologist at the time, recommended taking Benadryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the events and included treatment herself with Benadryl. The clinical outcome of the event swelling and redness darkened was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Discomfort, Fatigue, Headache, Pain
Clinical narrative: Severe chills and shivering; Total body aches; Fatigue; Unable to get comfortable; Headache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 07Apr2021 at 11:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included sertraline hydrochloride (ZOLOFT) and levocetirizine dihydrochloride (XYZAL) from an unknown date, for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 17Mar2021 at 15:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 02:30, the patient experienced severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache. Therapeutic measures were taken as a result of the events severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache and included treatment with Tylenol. The clinical outcome of the events severe chills and shivering, total body aches, fatigue, unable to get comfortable and headache were not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Myalgia, Pyrexia, Swelling
Clinical narrative: painful swelling in the armpit of left arm.; painful swelling in the armpit of left arm.; muscle pain; slight fever; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 16:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included severe obesity. The patient previously took sulfates and experienced allergy to it. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), acetylsalicylic acid (BABY ASPIRIN), fish oil (MANUFACTURER UNKNOWN) and multivitamins for an unknown indication from an unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 18:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 03:00, about 24 hours after the vaccination, the patient experienced muscle pain and slight fever. On 08Apr2021, in the morning at 04:00, 36 hours after the vaccination, the patient had painful swelling in the armpit of left arm and it was visibly swollen compared to the right armpit. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events muscle pain, slight fever and painful swelling in the armpit of left arm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Odynophagia, Oropharyngeal pain, Pharyngeal swelling, Scratch
Clinical narrative: Throat swollen and sore; Throat swollen and sore; Feels scratchy and hurts to swallow.; Feels scratchy and hurts to swallow.; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 06Apr2021 at 11:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included lupus, fibromyalgia, occasional high blood pressure. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), buspirone hydrochloride (BUSPAR), clonidine (MANUFACTURER UNKNOWN) and quetiapine fumarate (SEROQUEL) and biotin (MANUFACTURER UNKNOWN) from unknown dates for an unknown indication. The patient previously took risperidone (MANUFACTURER UNKNOWN) and experience drug allergy. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 03:00, the patient experienced throat swollen and sore, which occurred approximately 36 hours after the vaccine and also experienced feels scratchy and hurts to swallow. Therapeutic measures were not taken as a result of the events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events throat swollen, throat sore, feels scratchy and hurts to swallow was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Balance disorder, Constipation, Decreased appetite, Fatigue
Clinical narrative: Stiffness of neck mussels; Colon spasm; Constipation; Night sweats; Loss of appetite; Foods don't taste correct; Weight loss; Very vivid dreams; Not sleeping well/can't get enoughsleep; Balance is off; Headache; Fatigue; Tired all the time; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm right on 26Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removal. Concomitant medications included apixaban (ELIQUIS) from unknown date for unknown indication . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the arm left on 04Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient previously took Bactrim and Flagyl and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 patient experienced Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off. These symptoms still on going as of 4/8/21. On 23Mar2021, the patient underwent Nasal Swab SARS CoV-2 test and the result was Negative. Therapeutic measures included treatment with Given prescription "Hyoscyamine Sulfate 0.125 Mg for unknown event. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Musculoskeletal stiffness, Night sweats, Poor quality sleep
Clinical narrative: Stiffness of neck mussels; Colon spasm; Constipation; Night sweats; Loss of appetite; Foods don't taste correct; Weight loss; Very vivid dreams; Not sleeping well/can't get enoughsleep; Balance is off; Headache; Fatigue; Tired all the time; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm right on 26Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removal. Concomitant medications included apixaban (ELIQUIS) from unknown date for unknown indication . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the arm left on 04Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient previously took Bactrim and Flagyl and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 patient experienced Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off. These symptoms still on going as of 4/8/21. On 23Mar2021, the patient underwent Nasal Swab SARS CoV-2 test and the result was Negative. Therapeutic measures included treatment with Given prescription "Hyoscyamine Sulfate 0.125 Mg for unknown event. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Taste disorder, Weight decreased
Clinical narrative: Stiffness of neck mussels; Colon spasm; Constipation; Night sweats; Loss of appetite; Foods don't taste correct; Weight loss; Very vivid dreams; Not sleeping well/can't get enoughsleep; Balance is off; Headache; Fatigue; Tired all the time; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm right on 26Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder removal. Concomitant medications included apixaban (ELIQUIS) from unknown date for unknown indication . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the arm left on 04Feb2021 at 09:30(at the age of 74-year-old) as a single dose for COVID-19 immunisation. The patient previously took Bactrim and Flagyl and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 patient experienced Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off. These symptoms still on going as of 4/8/21. On 23Mar2021, the patient underwent Nasal Swab SARS CoV-2 test and the result was Negative. Therapeutic measures included treatment with Given prescription "Hyoscyamine Sulfate 0.125 Mg for unknown event. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Headache, Stiffness of neck mussels, Colon spasm, Constipation, Night sweats, Loss of appetite, Foods don't taste correct, Weight loss, Very vivid dreams, Fatigue, Not sleeping well, Tired all the time, can't get enough sleep. Balance is off were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Flushing, Hypoaesthesia oral, Rash, Swelling face
Clinical narrative: Face swelling; Itchy eyes; Red flushing on face and chest; Tongue numb; Rash on arms; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 15:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to cats. The patient did not receive any concomitant medication within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 15:30, the patient experienced face swelling, itchy eyes, red flushing on face and chest, tongue numb and rash on arms. It was unknown whether any therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visits. The clinical outcome of the events face swelling, itchy eyes, red flushing on face and chest, tongue numb and rash on arms were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, SARS-CoV-2 test
Clinical narrative: Tremendous lower back pain.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 09:00 (at the age of 46-years-old) as single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021 at 09:00, the patient experienced tremendous lower back pain. The patient underwent lab test on 19Mar2021 which included SARS-CoV-2 test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of tremendous lower back pain which included purchasing of heating pad. The clinical outcome of tremendous lower back pain was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Chills; Headache; Body ache; Dizziness; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E128734) via an unspecified route of administration in the arm left on 02Apr2021 at 13:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included dizziness which recovered with physical therapy and still patient felt like had a slight relapse in dizziness. Concomitant medications included vitamin B complex (B-complex), cetirizine 10 mg (MANUFACTURER UNKNOWN) and magnesium supplement (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 the patient experienced chills, headache, body ache, dizziness, nausea and fatigue and reported that all the symptoms lasting 6 days post-vaccine. The patient also reported that she felt better on day 3, then worse on day 4, better on day 5 and worse again on day 6. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills, headache, body ache, dizziness, nausea and fatigue were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Chills; Headache; Body ache; Dizziness; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E128734) via an unspecified route of administration in the arm left on 02Apr2021 at 13:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included dizziness which recovered with physical therapy and still patient felt like had a slight relapse in dizziness. Concomitant medications included vitamin B complex (B-complex), cetirizine 10 mg (MANUFACTURER UNKNOWN) and magnesium supplement (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 the patient experienced chills, headache, body ache, dizziness, nausea and fatigue and reported that all the symptoms lasting 6 days post-vaccine. The patient also reported that she felt better on day 3, then worse on day 4, better on day 5 and worse again on day 6. The patient did not receive any treatment for the reported events. The clinical outcome of the events chills, headache, body ache, dizziness, nausea and fatigue were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Headache, Migraine, Photophobia, Vision blurred
Clinical narrative: Symptoms of migraine; Light sensitivity; Headache; Discomfort; Difficult to focus on computer screen; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the right arm on 07Apr2021 at 11:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. Concomitant medications included calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) all for unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:00 the patient experienced symptoms of a migraine which the patient suffered periodically. She experienced specifically light sensitivity and headache. The light sensitivity persisted with sunlight and computer screen causing discomfort. The computer screen was difficult to focus on. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the events symptoms of migraine, light sensitivity, headache, discomfort and difficult to focus on computer screen was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Pain in extremity, Rash
Clinical narrative: Rash on top of foot; Burning toes; Sore toes; Red toes; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 05Apr2021 at 10:30 (at the age of 83-year-old), as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation (Afib). The patient did not have any allergies to food, medications, or other products. The patient received other medications (unspecified) within 2 weeks of vaccination. The patient previously received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 13Mar2021 at 15:15 (at the age of 83-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 22:00 (same day after injection), the patient woke up with burning and sore red toes. On 06Apr2021 (second day after injection), the patient woke up with sore red toes on left foot and rash on top of foot. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events burning toes, sore toes, red toes and rash on top of foot was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Musculoskeletal stiffness, Pain, Tinnitus
Clinical narrative: Ringing in ears; Left ear stuffiness; Migraine; Intense body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic fatigue, fibromyalgia and dysautonomia. The patient previously received penicillin for an unknown indication on an unknown date and experienced allergy. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO) and famotidine (PEPCID AC); all from unknown dates for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 13:15, the patient experienced ringing in ears, left ear stiffness, migraine and intense body aches. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of ringing in ears, left ear stiffness, migraine and intense body aches were not recovered at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site pain
Clinical narrative: Sleepy; Pain at the injection site; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On 05Apr2021, around 3 hours after the vaccination, the patient became sleepy, the feeling of sleepiness persisted until the next morning and the patient also experienced with some pain at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of sleepy and pain at the injection site was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus both ears; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El9263) via an unspecified route of administration in the left arm on 03Feb2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications included rosuvastatin calcium (CRESTOR), amitriptyline hydrochloride, chlordiazepoxide hydrochloride (LIMBITROL), losartan (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EI1284) via an unspecified route of administration in the left arm on 13Jan2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. On 15Feb2021, the patient experienced tinnitus both ears. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. The clinical outcome of tinnitus both ears was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste immediately after.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the arm right on 08Apr2021 at 11:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, CVID immune deficiency and ehlers-danlos syndrome. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 11:45, the patient experienced metallic taste immediately after. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event metallic taste immediately after was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Increased appetite, Pain
Clinical narrative: Aches; Increased hunger; Fatigue; Some diarrhea; Dizzy; Lightheadedness; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route in left arm on 06Apr2021 (at the age of 31-year-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 06Apr2021 at 17:00 hours, the patient had fatigue, aches, increased hunger, some diarrhea and after first 24 hours these subsided. On an unknown date in Apr2021, the patient experienced light headedness and dizzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of fatigue, aches, increased hunger, some diarrhea were recovered on 07Apr2021; while that of light headedness and dizzy was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nasopharyngitis, Sinusitis, Throat irritation
Clinical narrative: full blown head/sinus; chills; tiredness; feeling that throat was scratchy; little tired the following day after the 2nd dose.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, milk allergy and sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced a little tired the following day after the 2nd dose. On 05Apr2021 at 16:00, the patient experienced feeling that throat was scratchy. On 6Apr2021, experienced full-blown head/sinus cold accompanied by chills and tiredness with no fever. Patient did not receive any treatment for the events. The clinical outcome of the events tiredness, itchy throat, sinusitis, cold, chills was resolving at the time of reporting.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Body aches; fever; chills; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208 & ER8737), via an unspecified route of administration in the left arm on 06Apr2021 at 14:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient was allergic to gluten and latex. Concomitant medications included levothyroxine sodium (SYNTHROID) for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 20:00, the patient experienced body aches, fever, chills (which the patient expected) and swollen lymph nodes. No therapeutic measures were taken as a result of the adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcomes of the events body aches, fever, chills (which was she expected) and swollen lymph nodes were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Feeling of body temperature change, Nausea, Oral discomfort, Oral disorder
Clinical narrative: Achy; Nausea; hot and cold, 99temp at times; Bumps and burning in my mouth; Bumps and burning in my mouth; Ears ringing; Large bruise at injection sight.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old unknown gender patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included pancreatitis. The patient received unspecified medication within two weeks of vaccination. The patient previously took Atropine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00 the patient experienced achy, nausea, hot and cold, 99temp at times, bumps and burning in mouth, ears ringing and large bruise at injection sight. Bruised lasted still after 1 week. On 31Mar2021, the patient underwent lad test and procedures, which included body temperature and the result was 99temp. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events achy, nausea, hot and cold, bumps and burning in mouth, ringing ears and bruise at injection site was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Pain, Tinnitus, Vaccination site bruising
Clinical narrative: Achy; Nausea; hot and cold, 99temp at times; Bumps and burning in my mouth; Bumps and burning in my mouth; Ears ringing; Large bruise at injection sight.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old unknown gender patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included pancreatitis. The patient received unspecified medication within two weeks of vaccination. The patient previously took Atropine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:00 the patient experienced achy, nausea, hot and cold, 99temp at times, bumps and burning in mouth, ears ringing and large bruise at injection sight. Bruised lasted still after 1 week. On 31Mar2021, the patient underwent lad test and procedures, which included body temperature and the result was 99temp. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events achy, nausea, hot and cold, bumps and burning in mouth, ringing ears and bruise at injection site was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: Dizziness; Foggy brain; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 12:15 the patient experienced dizziness, foggy brain. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, foggy brain was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity
Clinical narrative: Sore arm; Fatigue; Chills; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 07Apr2021 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 17Mar2021 at 14:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 08:00, the patient experienced sore arm, fatigue, chills and nausea. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events sore arm, fatigue, chills and nausea. The clinical outcome of the events sore arm, fatigue, chills and nausea were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vaccination site pain
Clinical narrative: full ache at the site of the shot; prickly sensations in hand and finger tips; left harm has gone numb randomly three times; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 09:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021, the patient experienced numbness of upper arm. On 31Mar2021, the patient experienced prickling of hand. On 08Apr2021, the patient experienced vaccination site pain. Its reported that his left arm had gone numb randomly three times since the vaccine. The first time was while sleeping about 3 days following shot. He was not sleeping on the arm at the time and could find no logical explanation for the sudden numbness. The second time was while driving home 7 days following the shot. His arm suddenly went numb and had prickly sensations in hand and finger tips. The third time was 08Apr2021, 15 days following shot. The numbness was sudden and went away within 60 seconds but the prickly had persisted. There was also a full ache at the site of the shot. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of numbness of upper arm was recovered with sequelae on an unknown date in Apr2021 while the clinical outcome of the event of prickling of hand was not recovered at the time of this report and the clinical outcome of the event of vaccination site pain was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site vesicles
Clinical narrative: Fluid filled bubble right at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. The patient did not have any allergies to food, medications, or other products. Concomitant medications included insulin lispro (HUMALOG) and atorvastatin (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Erz613) via an unspecified route of administration in the right arm on 16Mar2021 at 15:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient developed a fluid filled bubble right at the injection site of the second dose. Two days later, it was still there. No therapeutic measures were taken as a result of the event. The clinical outcome of the event fluid filled bubble right at the injection site was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.